Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Pouillon

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Crohn'S & Colitis|January 9, 2018
It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel DiseaseLieven Pouillon, Laurent Peyrin-Biroulet
Journal of Crohn'S & Colitis|August 31, 2021
Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?Katrien Asnong, Lieven Pouillon, Peter Bossuyt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2018
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel DiseasesPeter Bossuyt, Eveline Hoefkens, Lieven Pouillon
Gastroenterology|August 13, 2019
An Unfortunate Consequence of Duodenogastric RefluxMichiel Bronswijk, Claire Bourgain, Lieven Pouillon
BMC Medicine|May 9, 2019
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overviewLieven Pouillon, Séverine Vermeire, Peter Bossuyt
United European Gastroenterology Journal|December 5, 2024
Towards a Greener IBD-Care: Let's INTERACT!Stephanie Louis, Nikki Lembrechts, Lieven Pouillon
Journal of Crohn'S & Colitis|October 26, 2020
Tofacitinib and Subacute Pneumonitis: Don't Hold Your BreathBram Verstockt, Lieven Pouillon, Peter Bossuyt
Nature Reviews. Gastroenterology & Hepatology|January 26, 2017
Primetime for e-health in IBD?Peter Bossuyt, Lieven Pouillon, Laurent Peyrin-Biroulet
Expert Opinion on Biological Therapy|June 23, 2016
Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel diseaseLieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Gastroenterology|August 1, 2017
Tofacitinib Is the Right OCTAVE for Ulcerative ColitisLieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Crohn'S & Colitis|January 9, 2018
It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel DiseaseLieven Pouillon, Laurent Peyrin-Biroulet
Journal of Crohn'S & Colitis|August 31, 2021
Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?Katrien Asnong, Lieven Pouillon, Peter Bossuyt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2018
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel DiseasesPeter Bossuyt, Eveline Hoefkens, Lieven Pouillon
Gastroenterology|August 13, 2019
An Unfortunate Consequence of Duodenogastric RefluxMichiel Bronswijk, Claire Bourgain, Lieven Pouillon
BMC Medicine|May 9, 2019
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overviewLieven Pouillon, Séverine Vermeire, Peter Bossuyt
United European Gastroenterology Journal|December 5, 2024
Towards a Greener IBD-Care: Let's INTERACT!Stephanie Louis, Nikki Lembrechts, Lieven Pouillon
Journal of Crohn'S & Colitis|October 26, 2020
Tofacitinib and Subacute Pneumonitis: Don't Hold Your BreathBram Verstockt, Lieven Pouillon, Peter Bossuyt
Nature Reviews. Gastroenterology & Hepatology|January 26, 2017
Primetime for e-health in IBD?Peter Bossuyt, Lieven Pouillon, Laurent Peyrin-Biroulet
Expert Opinion on Biological Therapy|June 23, 2016
Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel diseaseLieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Gastroenterology|August 1, 2017
Tofacitinib Is the Right OCTAVE for Ulcerative ColitisLieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Pageof 6